Selective serotonin re-uptake inhibitors in anorexia nervosa.
Anorexia nervosa (AN), one of the major eating disorders, is a primarily psychiatric illness affecting a number of adolescents and young adults. AN usually runs a chronic course and is associated with significant morbidity and mortality. Drug therapy has modest success in its treatment. Various pharmacotherapeutic agents are being tested, with variable success. Selective serotonin re-uptake inhibitors are the one class of drug that has been found to be effective in AN, especially in preventing relapse. This article provides an overview of the current literature on the role of selective serotonin re-uptake inhibitors in the treatment of AN.
Vaswani
Meera
M
Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India. meeravaswani@hotmail.com
Kalra
Harish
H
D000818:Animals; D000856:Anorexia Nervosa / Q000175:diagnosis / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
D017367:Selective Serotonin Reuptake Inhibitors